Correlation Between Summit Therapeutics and Verra Mobility

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and Verra Mobility at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and Verra Mobility into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Summit Therapeutics PLC and Verra Mobility Corp, you can compare the effects of market volatilities on Summit Therapeutics and Verra Mobility and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of Verra Mobility. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and Verra Mobility.

Diversification Opportunities for Summit Therapeutics and Verra Mobility

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Summit and Verra is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and Verra Mobility Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verra Mobility Corp and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with Verra Mobility. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verra Mobility Corp has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and Verra Mobility go up and down completely randomly.

Pair Corralation between Summit Therapeutics and Verra Mobility

Given the investment horizon of 90 days Summit Therapeutics PLC is expected to generate 4.05 times more return on investment than Verra Mobility. However, Summit Therapeutics is 4.05 times more volatile than Verra Mobility Corp. It trades about 0.08 of its potential returns per unit of risk. Verra Mobility Corp is currently generating about 0.25 per unit of risk. If you would invest  1,797  in Summit Therapeutics PLC on October 11, 2024 and sell it today you would earn a total of  85.00  from holding Summit Therapeutics PLC or generate 4.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Summit Therapeutics PLC  vs.  Verra Mobility Corp

 Performance 
       Timeline  
Summit Therapeutics PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Summit Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable primary indicators, Summit Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Verra Mobility Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Verra Mobility Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Summit Therapeutics and Verra Mobility Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Summit Therapeutics and Verra Mobility

The main advantage of trading using opposite Summit Therapeutics and Verra Mobility positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, Verra Mobility can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verra Mobility will offset losses from the drop in Verra Mobility's long position.
The idea behind Summit Therapeutics PLC and Verra Mobility Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Commodity Directory
Find actively traded commodities issued by global exchanges